reference standard CX-6258 {(E)-5-chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one, 4a} and its desmethylated precursor N-desmethyl-CX-6258 {(E)-3-((5-(3-(1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)-5-chloroindolin-2-one, 5} for radiolabeling were synthesized from 5-bromo-2-furaldehyde and 3-carboxybenzeneboronic acid in 3 and 4 steps with 29-49% and 24-32% overall chemical yield, respectively. The target tracer 11 C]CO2 and decay corrected to end of bombardment (EOB) with 370-1110 GBq/µmol specific activity at EOB.
Pim kinases (Provirus Integration site for Moloney murine leukemia virus) are a family of serine/threonine kinases, including three different members Pim1, Pim2 and Pim3. [1] [2] [3] This family of kinases regulates signaling pathways via Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway and plays pivotal roles in cancer development and progression. [4] [5] [6] Pim kinases including Pim1, Pim2 and Pim3 are overexpressed not only in hematologic malignancies but also in solid tumors, and have become an attractive targets for therapeutics in cancer. [7] [8] [9] [10] Many Pim kinases inhibitors have been discovered. 11, 12 Recently a potent, selective, and orally efficacious pan-Pim kinases inhibitor called CX-6258 has been developed by Cylene Pharmaceuticals, and the IC50 of CX-6258 is 5, 25, and 16 nM for Pim1, Pim2, and Pim3, respectively. 13 Pim kinases have also become a promising target for molecular imaging of Pim kinases-related cancers and image-guided therapy using the biomedical imaging technique positron emission tomography (PET). In our previous work, we have developed a series of radiolabeled (carbon-11 and fluorine-18) protein kinase (PK) inhibitors such as [ 11 Figure 1 , as new cancer imaging agents for PET to study PK and PK inhibitors. [14] [15] [16] [17] [18] [19] [20] In this ongoing study, we target Pim kinases. Here we report the design, synthesis and labeling of [ 11 chloroindolin-2-one, 5} were prepared based on the reported method 13 with modifications. As shown in Scheme 1, Suzuki cross-coupling of 3-carboxybenzeneboronic acid with 5-bromo-2-furaldehyde in the presence of aqueous 2 M Na2CO3 using Pd(OAc)2 as catalyst in toluene/EtOH to give 3-(5-formylfuran-2-yl)benzoic acid (1) in 89% yield. 21 Compounds 2a and 2b were achieved via amide bond coupling of acid 1 with homopiperazines in the presence of N,N-diisopropylethylamine (DIPEA) using O-(benzotriazo-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU) as coupling agent in N,Ndimethylformamide (DMF) with 75% and 64% yield, respectively. 22 Condensation of 5-chlorooxindole with aldehydes 2a and 2b using piperidine as catalyst in EtOH afforded standard compound 4a and N-Boc protected precursor 4b with 44% and 64% yield, respectively. 23 Compounds 4a and 4b could be obtained by reverse the above two steps in much higher yields. Condensation of compound 1 with 5-chlorooxindole using piperidine as catalyst in EtOH to provide acid 3 in 70% yield, which was coupled with homopiperazines using 1,1'-carbonyldimidazole (CDI) as coupling agent in DMF to provide 4a and 4b in 78% and 79% yield, respectively. The Boc group of 4b was removed with trifluoroacetic acid (TFA) in CH2Cl2 to afford the precursor 5 in 66% yield. Synthesis of the target tracer . 32 , and thus, the radiochemical yield of [ 11 C]4a was relatively higher. Basic condition would help the N-[ 11 C]methylation of precursor and significantly increase the radiochemical yield of [ 11 C]4a. Small amount of the precursor (0.3-0.5 mg) was used for radiolabeling instead of commonly used large amount of the precursor (1.0-1.5 mg), which improved the chemical purity of the final tracer solution. However, the small amount of precursor could potentially decrease the radiolabeling yield and increase the specific activity of the target tracer by decreasing the radiolabeling product as well as product mass. In addition, in order to make more product radioactivity, we also optimized the semi-preparative HPLC conditions including column, mobile phase and flow rate to shorten the retention time of [ 11 C]4a to 8-9 min. Addition of NaHCO3 solution to quench the radiolabeling reaction and to dilute the radiolabeling mixture prior to the injection onto the semi-preparative HPLC column for purification gave better separation of [ 11 C]4a from its desmethylated precursor 5. [29] [30] [31] 33 The radiosynthesis was performed in a home-built automated multi-purpose [ 11 C]-radiosynthesis module, allowing measurement of specific radioactivity during synthesis. [34] [35] [36] This [
11 C]-radiosynthesis module includes the overall design of the reaction, purification and reformulation capabilities of the prototype system. In addition, [ 11 C]-tracer specific activity (SA, GBq/µmol at EOB) can be automatically determined prior to product delivery for compounds purified by the HPLC-portion of the system. 36 12 C carrier-added as much as possible, then we will be able to achieve higher SA. The [
11 C]-gas target we used is the Siemens RDS-111 Eclipse cyclotron [ 11 C]-gas target. The technical trick to produce high SA [ 11 C]CO2 is we will usually do 2-3 times pre-burn with the same beam current and short time like 10 min before production run. This pre-burn will warm up the cyclotron and eliminate significant amount of 12 C carrier-added in the cyclotron [ 11 C]-gas target. The [ 11 C]CH3OTf production system we used is an Eckert & Ziegler Modular Lab C-11 Methyl Iodide/Triflate module, convenient gas phase bromination of [ 11 C]methane and production of [ 11 C]CH3OTf, a 'dry' method using Br2 different with other 'dry' method using I2 and 'wet' method using LiAlH4 and HI. Our system will have much less 12 C carrier-added in comparison with other 'dry' method and 'wet' method. 25 Chemical purity and radiochemical purity were determined by analytical HPLC. 38 The chemical purity of the precursor 5 and reference standard 4a was >93%. The radiochemical purity of the target tracer [ 11 C]4a was >99% determined by radio-HPLC through γ-ray (PIN diode) flow detector, and the chemical purity of [ 11 C]4a was >90% determined by RP HPLC through UV flow detector. A C-18 Plus Sep-Pak cartridge instead of rotatory evaporation was used for purification and isolation process to significantly improve the chemical purity of the tracer solution. [29] [30] [31] 38 In this study, the Sep-Pak purification further increased the chemical purity >10%. [29] [30] [31] The experimental details and characterization data for compounds 1-5 and for the tracer [ 11 C]4a are given. 39 In summary, a multi-step synthetic route with moderate to high yields for the synthesis of the precursor Ndesmethyl-CX-6258, reference standard CX-6258 and target tracer [ 25 Melting points were determined on a MEL-TEMP II capillary tube apparatus and were uncorrected.
1 H NMR spectra were recorded at 500 MHz on a Bruker Avance II 500 MHz NMR spectrometer using tetramethylsilane (TMS) as an internal standard. Chemical shift data for the proton resonances were reported in parts per million (ppm, δ scale) relative to internal standard TMS (δ 0.0), and coupling constants (J) were reported in hertz (Hz). Liquid chromatography-mass spectra (LC-MS) analysis was performed on an Agilent system, consisting of an 1100 series HPLC connected to a diode array detector and a 1946D mass spectrometer configured for positive-ion/negative-ion electrospray ionization. Chromatographic solvent proportions are indicated as volume:volume ratio. Thin-layer chromatography (TLC) was run using Analtech silica gel GF254 uniplates (5 × 10 cm 2 ). Plates were visualized under UV light. Preparative TLC was run using Analtech, silica gel UV 254 plates (20×20 cm 2 ). Normal phase flash column chromatography was carried out on EM Science silica gel 60 (230-400 mesh) with a forced flow of the indicated solvent system in the proportions described below. All moisture-and air-sensitive reactions were performed under a positive pressure of nitrogen maintained by a direct line from a nitrogen source. Analytical HPLC was performed using a Prodigy (Phenomenex) 5 µm C-18 column, 4.6 × 250 mm; mobile phase 30% CH3CN/70% 20 mM H3PO4; flow rate 2.0 mL/min; and UV (254 nm) and γ-ray (PIN diode) flow detectors. Semi-preparative HPLC was performed using a Prodigy (Phenomenex) 5 µm C-18 column, 12 nm, 10 × 250 mm; mobile phase 30% CH3CN/70% 20 mM H3PO4; 6.0 mL/min flow rate; UV (254 nm) and γ-ray (PIN diode) flow detectors. C18 Plus Sep-Pak cartridges were obtained from Waters Corporation (Milford, MA). Sterile Millex-FG 0.2 µm filter units were obtained from Millipore Corporation (Bedford, MA).
(b) 3-(5-Formylfuran-2-yl)benzoic acid (1):
To a mixture of 3-carboxybenzeneboronic acid (2.0 g, 12.05 mmol), 5-bromo-2-furaldehyde (2.11 g, 12.05 mmol), Pd(OAc)2 (135.3 mg, 0.60 mmol) and triphenyl phosphine (632.0 mg, 2.41 mmol) in toluene/EtOH (1:1, 72 mL) was added aqueous 2 M Na2CO3. After the reaction mixture was heated at reflux overnight, it was cooled to room temperature (RT). The mixture was diluted with water, washed with EtOAc. The aqueous layer was acidified with aqueous 6 M HCl to pH 1-2. The precipitate was collected by filtration, washed with water and dried in vacuo to afford compound 1 as an orange solid (2.31 g, 89%). 
. (c) 5-(3-(4-Methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-carbaldehyde (2a):
To a stirred solution of compound 1 (150 mg, 0.69 mmol) in anhydrous DMF (4 mL) was added HBTU (394 mg, 1.04 mmol), DIPEA (0.36 mL, 2.08 mmol) under N2 atmosphere. After the mixture was stirred at RT for 20 min, N-methylhomopiperazine (0.13 mL, 1.04 mmol) was added. The reaction mixture was stirred overnight. Water (15 mL) was added to quench the reaction, and the mixture was extracted with butanol. The combined organic layer was washed with water, brine and dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude product was purified by preparative TLC plates with CH2Cl2/MeOH (75:4) as eluent to afford compound 2a as an orange solid (163 mg, 75%). HBTU (524 mg, 1.38 mmol) , DIPEA (0.48 mL, 2.78 mmol) under N2 atmosphere. After the mixture was stirred at RT for 20 min, 1-Bochexahydro-1,4-diazapine (0.27 mL, 1.38 mmol) was added. The reaction mixture was stirred overnight. Water (20 mL) was added to quench the reaction, and the mixture was extracted with CH2Cl2. The combined organic layer was washed with water, brine and dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude product was purified by preparative TLC plates with CH2Cl2/MeOH (10:1) as eluent to afford compound 2b as an orange oil (235 mg, 64%). atmosphere. After the mixture was stirred at RT overnight, 1-Boc-hexahydro-1,4-diazapine (0.27 mL, 1.38 mmol) was added. The reaction mixture was stirred for 24 h. Water (15 mL) was added to quench the reaction, and the mixture was stirred for 1 h. The precipitate was collected by filtration, washed with water, dried in vacuo. The crude product was purified with preparative TLC plates with CH2Cl2/MeOH (50:3) as eluent to afford compound 4b as an orange solid (300 mg, 79%). Analytical data was identical with Method A.
To a stirred solution of compound 4b (80 mg, 0.15 mmol) in CH2Cl2 (1 mL) was added TFA (0.2 mL) dropwise at 0 ο C. After the reaction mixture was stirred for 4 h, the solvent was removed in vacuo. The crude product was washed with Et2O to afford compound 5 TFA salt as an orange solid (54 mg, 66% 11 C nuclear reaction in the small volume (9.5 cm 3 ) aluminum gas target provided with the Siemens RDS-111 Eclipse cyclotron. The target gas consisted of 1% oxygen in nitrogen purchased as a specialty gas from Praxair, Indianapolis, IN. Typical irradiations used for the development were 55 µA beam current and 30 min on target. The production run produced approximately 45.5 GBq of [ 11 C]CO2 at EOB. In a small reaction vial (5 mL), the precursor 5 (0.3-0.5 mg) was dissolved in DMSO (400 µL). To this solution was added NaH (1 mg). No carrier-added (high specific activity) [ 11 C]CH3OTf that was produced by the gas-phase production method 25 from [ 11 C]CO2 through [ 11 C]CH4 and [
11 C]CH3Br with silver triflate (AgOTf) column was passed into the reaction vial at RT, until radioactivity reached a maximum (~2 min), and then the reaction vial was isolated and heated at 80 ο C for 3 min. The contents of the reaction vial were diluted with NaHCO3 solution (0.1 M, 1 mL), and injected onto the semi-preparative RP HPLC column with 3 mL injection loop for purification. The product fraction was collected in a recovery vial containing 30 mL water. The diluted tracer solution was then passed through a C-18 Sep-Pak Plus cartridge, and washed with water (5 mL × 4). The cartridge was eluted with EtOH (1 mL × 2), followed by 10 mL saline, to release [ 11 C]4a. The eluted product was then sterilefiltered through a sterile vented Millex-FG 0.2 µm filter, and collected into a sterile vial. Total radioactivity (4.6-8.2 GBq) was assayed and total volume (10-11 mL) was noted for tracer dose dispensing. The overall synthesis, purification and formulation time was 30-40 min from EOB. Retention times in the analytical HPLC system were: tR 5 = 3.38 min, tR 4a = 5.51 min, tR 
